Product Information
METOCLOPRAMIDE 5 MG/5 ML SOLN is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.1257 per ML under NDC 62559019016. Its NADAC has been published 589 times since Jun 24, 2015.
FDA first approved this application on Jun 25, 1993. Its Orange Book therapeutic-equivalence code is AA.
Strength
5 mg/5mL
Manufacturer
ANI Pharmaceuticals, Inc.NDC
62559019016
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METOCLOPRAMIDE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA071402FDA Approved
6/25/1993
TE Code
AA
On Market Since
5/18/2015
Pharmacological Classes
Price Statistics
The NADAC for METOCLOPRAMIDE 5 MG/5 ML SOLN has been published 589 times since Jun 24, 2015, and over the history we have for it it has risen 987.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1257 per ML |
|---|---|
| All-time high | $0.1315 (Jan 14, 2026) |
| All-time low | $0.0106 (Oct 19, 2016) |
| 52-week high | $0.1315 |
| 52-week low | $0.1101 |
| Median price | $0.0374 |
| Average price | $0.0410 |
| Largest weekly change | +113.9% (Nov 22, 2017) |
| Weeks tracked | 589 |
| Tracking since | Jun 24, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Metoclopramide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ANI Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Metoclopramide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Dopamine-2 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METOCLOPRAMIDE 5 MG/5 ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for METOCLOPRAMIDE 5 MG/5 ML SOLN, manufactured by ANI Pharmaceuticals, Inc., is $0.1257 per ML (NDC 62559019016), effective Sep 30, 2026.
How has the price of METOCLOPRAMIDE 5 MG/5 ML SOLN changed over time?
Over the history we have for it, the NADAC for METOCLOPRAMIDE 5 MG/5 ML SOLN has risen 987.3%. It has been tracked across 589 weekly CMS publications since Jun 24, 2015.
What are the highest and lowest recorded NADAC prices for METOCLOPRAMIDE 5 MG/5 ML SOLN?
Since Jun 24, 2015, the NADAC for METOCLOPRAMIDE 5 MG/5 ML SOLN has ranged from a low of $0.0106 (Oct 19, 2016) to a high of $0.1315 (Jan 14, 2026), with a median of $0.0374 per ML.
Are there cheaper alternatives to METOCLOPRAMIDE 5 MG/5 ML SOLN?
No other NADAC-published product currently shares the active ingredient and strength of METOCLOPRAMIDE 5 MG/5 ML SOLN in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures METOCLOPRAMIDE 5 MG/5 ML SOLN?
METOCLOPRAMIDE 5 MG/5 ML SOLN (NDC 62559019016) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.